Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
about
Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza InfectionsParallel screening of wild-type and drug-resistant targets for anti-resistance neuraminidase inhibitorsExploring the chemical space of influenza neuraminidase inhibitorsComputer-based de novo designs of tripeptides as novel neuraminidase inhibitors.Perspective: Alchemical free energy calculations for drug discovery.Alchemical free energy methods for drug discovery: progress and challengesCombining crystallographic information and an aspherical-atom data bank in the evaluation of the electrostatic interaction energy in an enzyme-substrate complex: influenza neuraminidase inhibitionLigand scaffold hopping combining 3D maximal substructure search and molecular similarity.Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility.The evolutionary pattern of glycosylation sites in influenza virus (H5N1) hemagglutinin and neuraminidase.CISAPS: Complex Informational Spectrum for the Analysis of Protein Sequences.Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza virusesEffects of Biomolecular Flexibility on Alchemical Calculations of Absolute Binding Free EnergiesViral membrane fusion: is glycoprotein G of rhabdoviruses a representative of a new class of viral fusion proteins?Binding of small-molecule ligands to proteins: "what you see" is not always "what you get".Zwitterionic structures: from physicochemical properties toward computer-aided drug designs.Analysis of oseltamivir resistance substitutions in influenza virus glycoprotein neuraminidase using a lentivirus-based surrogate assay system.Molecular docking, synthesis, and biological evaluation of naphthoquinone as potential novel scaffold for H5N1 neuraminidase inhibition.Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: the hydrophobic side chain influences type A subtype selectivity.Mutation effects of neuraminidases and their docking with ligands: a molecular dynamics and free energy calculation study.A rigid bicyclic platform for the generation of conformationally locked neuraminidase inhibitors.Impact of calcium on N1 influenza neuraminidase dynamics and binding free energy.Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
P2860
Q26749578-87DF1E5C-3D7E-4EBD-B350-1CAB75AB7D54Q28486252-17B6E8DA-1363-40DA-9368-EC03F962A2DCQ28834425-C056AB6E-F41A-4930-B7B9-563FEE674120Q30403144-CB23F57E-CE37-47FB-8CDC-3309A814C308Q30422862-E22DA934-A014-4A86-A190-E58A69141E1AQ30427576-16D28739-40EB-497C-9132-6C7E4ABE6D6FQ33434347-63AE4DAA-2946-4D65-A875-D0D3965FBE53Q33492553-8053BC52-EEE4-4D92-983F-32A15EEE4878Q34077100-83B2025E-C926-4581-B78C-30B35B123991Q34469957-44A31446-2C00-4475-8626-A8D2787569E8Q34999522-C4E45D67-F79F-465A-84CE-5BD8542662D4Q35024169-DB74FC90-7C8B-44AC-9B6A-E8873E8AE3F0Q35137099-C0F2C7E4-6E16-43B0-9F92-BBB631E693DFQ36149638-19087BED-24F5-43BD-935D-44C67F46B226Q37372747-6E2B8075-21B3-4AC9-9544-7AAFFB976B0FQ38792090-0615DC85-5375-4526-BBD9-0F5075612E7CQ39198919-1AD08413-3652-4AF0-9E5C-FBAC444F617AQ40408390-DE27FB49-12D2-4063-A884-A889E9E4DD6BQ42244266-88096D6E-0DEA-425C-988A-BFF6502E0CEEQ42256315-1F055FD8-78AE-4FB6-B305-85CB82364E39Q42396488-15EC59D6-88F4-4B7F-A1DB-646BB3A4E1EFQ42734341-B63E60F2-FED8-4375-9278-76E0E228BDB0Q47607908-9220ECDB-5EC7-4ADE-86E5-ED9CD0A4E661
P2860
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
@en
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
@nl
type
label
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
@en
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
@nl
prefLabel
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
@en
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
@nl
P2093
P356
P1433
P1476
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
@en
P2093
April L Kennedy
Ayda Saldivar
Clarence J Maring
Dale Kempf
Darold L Madigan
Graeme Laver
Hing L Sham
Jonathan Greer
P304
P356
10.1021/BI0205449
P407
P577
2003-01-01T00:00:00Z